ASH 2020: Chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukaemia
A study led by The University of Texas MD Anderson Cancer Center, USA, showed that…
Browsing: blinatumomab
ASH 2019: Immunotherapy superior to chemotherapy for children with relapsed B-ALL
The immunotherapy drug blinatumomab significantly improved survival in children with relapsed B-acute lymphoblastic leukaemia (B-ALL)…
Blinatumomab significantly improved overall survival in patients with b-cell precursor acute lymphoblastic leukaemia compared to chemotherapy
The New England Journal of Medicine published results from the Phase 3 TOWER study evaluating the efficacy…